Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR T-cells. This breakthrough enhances tumor targeting while reducing off-target effects, paving the way for advanced synthetic biology applications.

Sanders blames food companies for diabetes epidemic

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry. Sanders held a hearing today on diabetes that implicated both the

December 14, 2023

Inhaled vaccines could stop Covid infections, monkey studies show

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we

December 20, 2023

Psychedelics Companies Reeling After FDA Vote | Psychedelic Invest

Here’s what investors need to know. Shares of prominent psychedelics companies, including Compass Pathways, Atai Life Sciences, and Mind Medicine, experienced a significant decline following

June 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.